Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FNV9E
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,528
Award facts
- Contract value 100% obligated
- $19,527.75 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $19,527.75 delivery order to Amerisourcebergen Drug Corp on March 10, 2026, for Dupixent 300 mg/2 ml pen (2 ml) pharmaceutical supply, with an ultimate completion date of March 11, 2026.
The order is issued under the parent IDC held with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at up to $999,999,999.00 through December 2026. Place of performance is Conshohocken, PA. The order carries firm fixed pricing and no set-aside.
Quick answers
Who was awarded contract SPE2DR26FNV9E?
SPE2DR26FNV9E was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on March 10, 2026.
How much is contract SPE2DR26FNV9E worth?
The government has obligated $19,528 on SPE2DR26FNV9E.
Is contract SPE2DR26FNV9E an order under another contract?
Yes. SPE2DR26FNV9E is a delivery order under SPE2DR25D1021, an indefinite delivery contract.
Was contract SPE2DR26FNV9E competed?
The extent of competition for SPE2DR26FNV9E was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award